Αρχειοθήκη ιστολογίου

Τρίτη 27 Φεβρουαρίου 2018

Landiolol hydrochloride to successfully treat refractory ventricular arrhythmia during weaning from cardiopulmonary bypass

We effectively treated refractory ventricular arrhythmia (RVA) at the time of weaning from the cardiopulmonary bypass (CPB) during aortic valve replacement with landiolol for three patients who failed to respond to electrical defibrillation. Demographic data, comorbid factors, and preoperative finding were noted [Table 1].

http://ift.tt/2oss0iX

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου